Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosis

被引:81
作者
Marini, P
Schmid, A
Jendrossek, V
Faltin, H
Daniel, PT
Budach, W
Belka, C
机构
[1] Univ Tubingen, Dept Radiat Oncol, D-72076 Tubingen, Germany
[2] Univ Med Ctr Charite, D-13125 Berlin, Germany
[3] Dept Radiotherapy & Radiat Oncol, D-40225 Dusseldorf, Germany
关键词
D O I
10.1186/1471-2407-5-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: TRAIL (tumor necrosis factor related apoptosis inducing ligand) is an apoptosis inducing ligand with high specificity for malignant cell systems. Combined treatment modalities using TRAIL and cytotoxic drugs revealed highly additive effects in different tumour cell lines. Little is known about the efficacy and underlying mechanistic effects of a combined therapy using TRAIL and ionising radiation in solid tumour cell systems. Additionally, little is known about the effect of TRAIL combined with radiation on normal tissues. Methods: Tumour cell systems derived from breast-(MDA MB231), lung-(NCI H460) colorectal-(Colo 205, HCT-15) and head and neck cancer (FaDu, SCC-4) were treated with a combination of TRAIL and irradiation using two different time schedules. Normal tissue cultures from breast, prostate, renal and bronchial epithelia, small muscle cells, endothelial cells, hepatocytes and fibroblasts were tested accordingly. Apoptosis was determined by fluorescence microscopy and western blot determination of PARP processing. Upregulation of death receptors was quantified by flow cytometry. Results: The combined treatment of TRAIL with irradiation strongly increased apoptosis induction in all treated tumour cell lines compared to treatment with TRAIL or irradiation alone. The synergistic effect was most prominent after sequential application of TRAIL after irradiation. Upregulation of TRAIL receptor DR5 after irradiation was observed in four of six tumour cell lines but did not correlate to tumour cell sensitisation to TRAIL. TRAIL did not show toxicity in normal tissue cell systems. In addition, pre-irradiation did not sensitise all nine tested human normal tissue cell cultures to TRAIL. Conclusions: Based on the in vitro data, TRAIL represents a very promising candidate for combination with radiotherapy. Sequential application of ionising radiation followed by TRAIL is associated with an synergistic induction of cell death in a large panel of solid tumour cell lines. However, TRAIL receptor upregulation may not be the sole mechanism by which sensitation to TRAIL after irradiation is induced.
引用
收藏
页数:11
相关论文
共 71 条
[11]  
CHINNAIYAN AM, 1995, CELL, V81, P512
[12]   Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice [J].
Cretney, E ;
Takeda, K ;
Yagita, H ;
Glaccum, M ;
Peschon, JJ ;
Smyth, MJ .
JOURNAL OF IMMUNOLOGY, 2002, 168 (03) :1356-1361
[13]   Synergistic induction of apoptosis by the combination of TRAIL and chemotherapy in chemoresistant ovarian cancer cells [J].
Cuello, M ;
Ettenberg, SA ;
Nau, MM ;
Lipkowitz, S .
GYNECOLOGIC ONCOLOGY, 2001, 81 (03) :380-390
[14]   Guardians of cell death:: the Bcl-2 family proteins [J].
Daniel, PT ;
Schulze-Osthoff, K ;
Belka, C ;
Güner, D .
PROGRAMMED CELL DEATH, 2003, 39 :73-88
[15]   Chemotherapy: targeting the mitochondrial cell death pathway [J].
Debatin, KM ;
Poncet, D ;
Kroemer, G .
ONCOGENE, 2002, 21 (57) :8786-8803
[16]   The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain [J].
Degli-Esposti, MA ;
Dougall, WC ;
Smolak, PJ ;
Waugh, JY ;
Smith, CA ;
Goodwin, RG .
IMMUNITY, 1997, 7 (06) :813-820
[17]   Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family [J].
DegliEsposti, MA ;
Smolak, PJ ;
Walczak, H ;
Waugh, J ;
Huang, CP ;
DuBose, RF ;
Goodwin, RG ;
Smith, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) :1165-1170
[18]   Ionizing radiation sensitizes erythroleukemic cells but not normal erythroblasts to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by selective up-regulation of TRAIL-R1 [J].
Di Pietro, R ;
Secchiero, P ;
Rana, R ;
Gibellini, D ;
Visani, G ;
Bemis, K ;
Zamai, L ;
Miscia, S ;
Zauli, G .
BLOOD, 2001, 97 (09) :2596-2603
[19]   Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL [J].
Emery, JG ;
McDonnell, P ;
Burke, MB ;
Deen, KC ;
Lyn, S ;
Silverman, C ;
Dul, E ;
Appelbaum, ER ;
Eichman, C ;
DiPrinzio, R ;
Dodds, RA ;
James, IE ;
Rosenberg, M ;
Lee, JC ;
Young, PR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (23) :14363-14367
[20]   Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis [J].
Engels, IH ;
Stepczynska, A ;
Stroh, C ;
Lauber, K ;
Berg, C ;
Schwenzer, R ;
Wajant, H ;
Jänicke, RUU ;
Porter, AG ;
Belka, C ;
Gregor, M ;
Schulze-Osthoff, K ;
Wesselborg, S .
ONCOGENE, 2000, 19 (40) :4563-4573